The global cardiac biomarker market is anticipated to grow at a CAGR of over 7% during the forecast. Rising incidences and prevalence of cardiovascular diseases (CVDs) across the globe are one of the major factors that are fuelling the market growth over the forecast period. According to the WHO, CVDs are considered one of the major causes of mortality across the globe, accounting for more than 17.3 million mortalities per year.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cardiac-biomarkers-market
According to the American Heart Society, in 2017, CVDs are the cause of around 800 thousand mortalities in the US. Heart disease is the leading cause of mortality across the globe and the US; around 370,000 Americans lose their lives every year. The increasing prevalence of cardiovascular diseases encourages market players to focus on R&D and is expected to drive the market in the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment covered-
o By Type
o By Application
o By Location Of Testing
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the world
- Competitive landscape- Abbott Laboratories Inc., Biomerieux, Bio-Rad Laboratories, Randox Laboratories Ltd., Siemens AG, and Thermo Fisher Scientific Inc
Key Questions Addressed by the Report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-covid-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Cardiac Biomarker Market Report Segment
By Type
- Creatine Kinase(CK-MB)
- Troponins(T,I)
- Myoglobin
- Ischemia Modified Albumin
- Others
By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
By Location of Testing
- Laboratory Testing
- Point of Care Testing
A full report of Cardiac Biomarker Market is available at: https://www.omrglobal.com/industry-reports/cardiac-biomarkers-market
Cardiac Biomarker Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Laboratories Inc.
- Alere Inc.
- Becton, Dickson & Co.
- BG Medicine Inc.
- BioMérieux S.A.
- Bio-Rad Laboratories Inc.
- Cisbio Bioassays SAS
- Creative Diagnostics
- Critical Diagnostics
- Hoffmann La Roche Ltd.
- HyTest Ltd
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
